Neurology Minute

Pharmacy Benefits and Disease-Modifying Therapies

Informações:

Synopsis

Dr. Daniel Hartung discusses the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis. Show references: https://cp.neurology.org/content/12/1/36 https://www.neurology.org/podcast